Literature DB >> 26659591

Silica-coated Gd(DOTA)-loaded protein nanoparticles enable magnetic resonance imaging of macrophages.

Michael A Bruckman1, Lauren N Randolph1, Neetu M Gulati2, Phoebe L Stewart2, Nicole F Steinmetz3.   

Abstract

The molecular imaging of in vivo targets allows non-invasive disease diagnosis. Nanoparticles offer a promising platform for molecular imaging because they can deliver large payloads of imaging reagents to the site of disease. Magnetic resonance imaging (MRI) is often preferred for clinical diagnosis because it uses non-ionizing radiation and offers both high spatial resolution and excellent penetration. We have explored the use of plant viruses as the basis of for MRI contrast reagents, specifically Tobacco mosaic virus (TMV), which can assemble to form either stiff rods or spheres. We loaded TMV particles with paramagnetic Gd ions, increasing the ionic relaxivity compared to free Gd ions. The loaded TMV particles were then coated with silica maintaining high relaxivities. Interestingly, we found that when Gd(DOTA) was loaded into the interior channel of TMV and the exterior was coated with silica, the T1 relaxivities increased by three-fold from 10.9 mM-1 s-1 to 29.7 mM-1s-1 at 60 MHz compared to uncoated Gd-loaded TMV. To test the performance of the contrast agents in a biological setting, we focused on interactions with macrophages because the active or passive targeting of immune cells is a popular strategy to investigate the cellular components involved in disease progression associated with inflammation. In vitro assays and phantom MRI experiments indicate efficient targeting and imaging of macrophages, enhanced contrast-to-noise ratio was observed by shape-engineering (SNP > TMV) and silica-coating (Si-TMV/SNP > TMV/SNP). Because plant viruses are in the food chain, antibodies may be prevalent in the population. Therefore we investigated whether the silica-coating could prevent antibody recognition; indeed our data indicate that mineralization can be used as a stealth coating option to reduce clearance. Therefore, we conclude that the silica-coated protein-based contrast agent may provide an interesting candidate material for further investigation for in vivo delineation of disease through macrophage imaging.

Entities:  

Year:  2015        PMID: 26659591      PMCID: PMC4675143          DOI: 10.1039/C5TB01014D

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  43 in total

1.  Cellular uptake behaviour, photothermal therapy performance, and cytotoxicity of gold nanorods with various coatings.

Authors:  Xiao-Ming Zhu; Caihong Fang; Henglei Jia; Yu Huang; Christopher H K Cheng; Chun-Hay Ko; Zhiyi Chen; Jianfang Wang; Yi-Xiang J Wang
Journal:  Nanoscale       Date:  2014-10-07       Impact factor: 7.790

2.  Synthesis of uniform silica rods, curved silica wires, and silica bundles using filamentous fd virus as a template.

Authors:  Zhenkun Zhang; Johan Buitenhuis
Journal:  Small       Date:  2007-03       Impact factor: 13.281

Review 3.  Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.

Authors:  Marina A Dobrovolskaia; Parag Aggarwal; Jennifer B Hall; Scott E McNeil
Journal:  Mol Pharm       Date:  2008-05-30       Impact factor: 4.939

4.  Biocompatible magnetite nanoparticles with varying silica-coating layer for use in biomedicine: physicochemical and magnetic properties, and cellular compatibility.

Authors:  Rajendra K Singh; Tae-Hyun Kim; Kapil D Patel; Jonathan C Knowles; Hae-Won Kim
Journal:  J Biomed Mater Res A       Date:  2012-03-23       Impact factor: 4.396

Review 5.  Silica biomineralization via the self-assembly of helical biomolecules.

Authors:  Ben Liu; Yuanyuan Cao; Zhehao Huang; Yingying Duan; Shunai Che
Journal:  Adv Mater       Date:  2014-10-22       Impact factor: 30.849

6.  Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.

Authors:  Derrick Tarn; Carlee E Ashley; Min Xue; Eric C Carnes; Jeffrey I Zink; C Jeffrey Brinker
Journal:  Acc Chem Res       Date:  2013-02-06       Impact factor: 22.384

7.  Viral capsids as MRI contrast agents.

Authors:  Lars Liepold; Stasia Anderson; Deborah Willits; Luke Oltrogge; Joseph A Frank; Trevor Douglas; Mark Young
Journal:  Magn Reson Med       Date:  2007-11       Impact factor: 4.668

Review 8.  Imaging and nanomedicine in inflammatory atherosclerosis.

Authors:  Willem J M Mulder; Farouc A Jaffer; Zahi A Fayad; Matthias Nahrendorf
Journal:  Sci Transl Med       Date:  2014-06-04       Impact factor: 17.956

9.  Nanomanufacturing of Tobacco Mosaic Virus-Based Spherical Biomaterials Using a Continuous Flow Method.

Authors:  Michael A Bruckman; Allen VanMeter; Nicole F Steinmetz
Journal:  ACS Biomater Sci Eng       Date:  2014-12-09

10.  Humans have antibodies against a plant virus: evidence from tobacco mosaic virus.

Authors:  Ruolan Liu; Radhika A Vaishnav; Andrew M Roberts; Robert P Friedland
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more
  14 in total

1.  Multiple Administrations of Viral Nanoparticles Alter in Vivo Behavior-Insights from Intravital Microscopy.

Authors:  Sourabh Shukla; R Dixon Dorand; Jay T Myers; Sarah E Woods; Neetu M Gulati; Phoebe L Stewart; Ulrich Commandeur; Alex Y Huang; Nicole F Steinmetz
Journal:  ACS Biomater Sci Eng       Date:  2016-03-30

Review 2.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

3.  Polydopamine-decorated tobacco mosaic virus for photoacoustic/magnetic resonance bimodal imaging and photothermal cancer therapy.

Authors:  He Hu; Qi Yang; Simona Baroni; Hong Yang; Silvio Aime; Nicole F Steinmetz
Journal:  Nanoscale       Date:  2019-05-16       Impact factor: 7.790

Review 4.  Structurally Modified Plant Viruses and Bacteriophages with Helical Structure. Properties and Applications.

Authors:  Olga A Kondakova; Ekaterina A Evtushenko; Oleg A Baranov; Nikolai A Nikitin; Olga V Karpova
Journal:  Biochemistry (Mosc)       Date:  2022-06       Impact factor: 2.824

5.  Serum albumin 'camouflage' of plant virus based nanoparticles prevents their antibody recognition and enhances pharmacokinetics.

Authors:  Andrzej S Pitek; Slater A Jameson; Frank A Veliz; Sourabh Shukla; Nicole F Steinmetz
Journal:  Biomaterials       Date:  2016-02-23       Impact factor: 12.479

6.  Nitroxyl Modified Tobacco Mosaic Virus as a Metal-Free High-Relaxivity MRI and EPR Active Superoxide Sensor.

Authors:  Madushani Dharmarwardana; André F Martins; Zhuo Chen; Philip M Palacios; Chance M Nowak; Raymond P Welch; Shaobo Li; Michael A Luzuriaga; Leonidas Bleris; Brad S Pierce; A Dean Sherry; Jeremiah J Gassensmith
Journal:  Mol Pharm       Date:  2018-05-29       Impact factor: 4.939

7.  The in vivo fates of plant viral nanoparticles camouflaged using self-proteins: overcoming immune recognition.

Authors:  N M Gulati; A S Pitek; A E Czapar; P L Stewart; N F Steinmetz
Journal:  J Mater Chem B       Date:  2018-02-27       Impact factor: 6.331

Review 8.  The pharmacology of plant virus nanoparticles.

Authors:  Christian Isalomboto Nkanga; Nicole F Steinmetz
Journal:  Virology       Date:  2021-01-28       Impact factor: 3.616

9.  Modified TMV Particles as Beneficial Scaffolds to Present Sensor Enzymes.

Authors:  Claudia Koch; Katrin Wabbel; Fabian J Eber; Peter Krolla-Sidenstein; Carlos Azucena; Hartmut Gliemann; Sabine Eiben; Fania Geiger; Christina Wege
Journal:  Front Plant Sci       Date:  2015-12-24       Impact factor: 5.753

Review 10.  Novel roles for well-known players: from tobacco mosaic virus pests to enzymatically active assemblies.

Authors:  Claudia Koch; Fabian J Eber; Carlos Azucena; Alexander Förste; Stefan Walheim; Thomas Schimmel; Alexander M Bittner; Holger Jeske; Hartmut Gliemann; Sabine Eiben; Fania C Geiger; Christina Wege
Journal:  Beilstein J Nanotechnol       Date:  2016-04-25       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.